• Outlook Therapeutics, Inc. (NASDAQ:OTLK) Receives Average Recommendation of "Moderate Buy" from Brokerages

    Source: Buzz FX / 07 Feb 2025 04:41:11   America/Chicago


    Outlook Therapeutics, Inc. (NASDAQ:OTLK) Receives Average Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat February 7, 2025 Share Link copied to clipboard. Shares of Outlook Therapeutics, Inc.
    Read more...
Share on,